Detection of a Tadalafil Analogue as an Adulterant in a Dietary Supplement for Erectile Dysfunction

Journal of Sexual Medicine

Volumn 12, Issue 1, 2015, Pages 152-157

  Ulloa, Jeronimo ^a   Sambrotta, Luis ^b   Redko, Flavia ^a   Mazza, Osvaldo Nestor ^c   Garrido, Gustavo ^c   Becher, Edgardo F ^c   Muschietti, Liliana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b LANAIS ^*  (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Adulteration; Aminotadalafil; Dietary Supplements; Erectile Dysfunction; PDE 5 Inhibitor Analogues

Indexed keywords

AMINOTADALAFIL; PHOSPHODIESTERASE V INHIBITOR; TADALAFIL; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; CARBOLINE DERIVATIVE; DRUG; PLANT MEDICINAL PRODUCT;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ERECTILE DYSFUNCTION; HERBAL MEDICINE; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; ADVERSE EFFECTS; ANALYSIS; ARGENTINA; CHEMISTRY; DRUG CONTAMINATION; HUMAN; MALE; PREVENTION AND CONTROL;

ARGENTINA; BENZODIOXOLES; CARBOLINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; DRUG CONTAMINATION; ERECTILE DYSFUNCTION; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; PHOSPHODIESTERASE 5 INHIBITORS; PLANT PREPARATIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84923229038     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12759     Document Type: Article

References (14)

1. Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED Jr, Rellini AH, Segraves T. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010;7:1598-1607.
2. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56.
3. Lin M-C, Liu Y-C, Lin Y-L, Lin J-H. Identification of a tadalafil analogue adulterated in a dietary supplement. J Food Drug Anal 2009;17:451-458.
4. Sheu MT, Wu AB, Yeh GC, Hsia A, Ho HO. Development of a liquid chromatographic method for bioanalytical applications with sildenafil. J Chromatogr B Analyt Technol Biomed Life Sci 2003;791:255-262.
5. Manallack DT, Hughes RA, Thompson PE. The next generation of phosphodiesterase inhibitors: Structural clues to ligand and substrate selectivity of phosphodiesterases. J Med Chem 2005;48:3449-3462.
6. Campbell N, Clark JP, Stecher VJ, Thomas JW, Callanan AC, Brian BA, Donnelly F, Goldstein I, Kaminetsky JC. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med 2013;10:1842-1849.
7. Blok-Tip L, Zomer B, Bakker F, Hartog KD, Hamzink M, ten Hove J, Vredenbregt M, de Kaste D. Structure elucidation of sildenafil analogues in herbal products. Food Addit Contam 2004;21:737-748.
8. Oh SS, Zou P, Low MY, Koh HL. Detection of sildenafil analogues in herbal products for erectile dysfunction. J Toxicol Environ Health A 2006;69:1951-1958.
9. Venhuis BJ, de Kaste D. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks. J Pharm Biomed Anal 2012;69:196-208.
10. Zou P, Hou P, Low M-Y, Koh H-L. Structural elucidation of a tadalafil analogue found as an adulterant of an herbal product. Food Addit Contam 2006;23:446-451.
11. Lee ES, Kim JW, Lee JH, Han KM, Cho S, Hwang I, Han SY, Chae K, Kim J. Identification of a new tadalafil analogue found in a dietary supplement. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2013;30:621-626.
12. Abdel-Aziz AA, Asiri YA, El-Azab AS, Al-Omar MA, Kunieda T. Tadalafil. Profiles Drug Subst Excip Relat Methodol 2011;36:287-329.
13. Singh S, Prasad B, Savaliya AA, Shah RP, Gohil VM, Kaur A. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. Trends Anal Chem 2009;28:13-28.
14. Fleshner N, Harvey M, Adomat H, Wood C, Eberding A, Hersey K, Guns E. Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors. J Urol 2005;174:636-641.